Li Yuqiang, Wang Dan, Ge Heming, Güngör Cenap, Gong Xuejun, Chen Yongheng
Department of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, China.
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China.
Pharmaceuticals (Basel). 2022 Nov 8;15(11):1369. doi: 10.3390/ph15111369.
Cancer stem cells (CSCs) are a subpopulation of cancer cells possessing stemness characteristics that are closely associated with tumor proliferation, recurrence and resistance to therapy. Recent studies have shown that different cytoskeletal components and remodeling processes have a profound impact on the behavior of CSCs. In this review, we outline the different cytoskeletal components regulating the properties of CSCs and discuss current and ongoing therapeutic strategies targeting the cytoskeleton. Given the many challenges currently faced in targeted cancer therapy, a deeper comprehension of the molecular events involved in the interaction of the cytoskeleton and CSCs will help us identify more effective therapeutic strategies to eliminate CSCs and ultimately improve patient survival.
癌症干细胞(CSCs)是具有干性特征的癌细胞亚群,与肿瘤增殖、复发及治疗抗性密切相关。最近的研究表明,不同的细胞骨架成分和重塑过程对癌症干细胞的行为有深远影响。在本综述中,我们概述了调节癌症干细胞特性的不同细胞骨架成分,并讨论了针对细胞骨架的现有及正在进行的治疗策略。鉴于目前靶向癌症治疗面临诸多挑战,更深入地理解细胞骨架与癌症干细胞相互作用中涉及的分子事件,将有助于我们确定更有效的治疗策略以消除癌症干细胞并最终提高患者生存率。